CANDICE CHARLES: Open Payments
NPI 1750135224 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Exact Sciences Corporation | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Cycle Pharmaceuticals Inc | 1 | $17 |
Products named: KESIMPTA, Cologuard Collection Kit, TRELEGY ELLIPTA, CREXONT, Ormalvi.
Industry payments across TX — which companies pay providers there.
